Authors
Loading...
Commentary highlights lipid monitoring needs in patients on enzyme-inducing antiseizure medications, suggesting psychotropic co-prescriptions alter cardiovascular risk.
Tan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: